Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05189977 · ClinicalTrials.gov registry record · Phase 1
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
A Phase 1 study, sponsored by Otsuka Pharmaceutical Development & Commercialization.
- Terminated
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT05189977 is a Phase 1 study that was terminated before completion, run by Otsuka Pharmaceutical Development & Commercialization. The registered enrollment target is 34 participants.
The verdict
NCT05189977, a Phase 1 study, was terminated before completion, sponsored by Otsuka Pharmaceutical Development & Commercialization.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
Interventions
- DRUG Propranolol
- DRUG Prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-09-07 |
| Est. Completion | 2023-08-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05189977
The ClinicalTrials.gov registry entry for NCT05189977 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otsuka Pharmaceutical Development & Commercialization, which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Propranolol is the first listed.
NCT05189977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05189977 about?
NCT05189977 is a clinical study titled "A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline". A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
What is the current status of trial NCT05189977?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2022-09-07. Estimated completion is 2023-08-03.
What interventions are being tested in trial NCT05189977?
The interventions under investigation include: Propranolol (DRUG), Prazosin (DRUG).
Who is sponsoring clinical trial NCT05189977?
This trial is sponsored by Otsuka Pharmaceutical Development & Commercialization, which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.